Adimab Program Inventions. As between the Parties, Adimab shall have the sole right, at its sole expense and in its sole discretion, to prepare, file, prosecute, enforce and maintain (including conducting or participating in interferences and oppositions) all Patents directed to Adimab Program Inventions but not falling within the Optioned Program Antibody Patents or the Adimab Platform Technology Improvements (which, to avoid doubt, are both addressed above).
Appears in 4 contracts
Samples: Collaboration Agreement (Leap Therapeutics, Inc.), Collaboration Agreement (iTeos Therapeutics, Inc.), Collaboration Agreement (iTeos Therapeutics, Inc.)
Adimab Program Inventions. As between the Parties, Adimab shall have the sole right, at its sole expense and in its sole discretion, to prepare, file, prosecute, enforce and maintain (including conducting or participating in interferences and oppositions) all Program Patents directed to claiming Adimab Program Inventions but not falling within the Optioned Program Antibody Patents Patents, the Adimab Platform/Core Technology Improvements, or the Adimab Platform Technology Improvements Broad Target/Non-CDR Antibody Inventions (which, to avoid doubt, are both all addressed above).
Appears in 2 contracts
Samples: Collaboration Agreement (Compass Therapeutics, Inc.), Collaboration Agreement (Alector, Inc.)
Adimab Program Inventions. As between the Parties, Adimab shall have the sole right, at its sole expense and in its sole discretionexpense, to prepare, file, prosecute, enforce and maintain (including conducting or participating in interferences and oppositionsoppositions and the like) (collectively “Prosecute”) all Patents directed to Adimab Program Inventions but not falling within the Optioned Program Antibody Patents or the Adimab Platform Technology Improvements (which, to avoid doubt, are both addressed above).
Appears in 2 contracts
Samples: Development and Option Agreement (Coherus BioSciences, Inc.), Development and Option Agreement (Surface Oncology, Inc.)
Adimab Program Inventions. As between the Parties, Adimab Adimab. shall have the sole right, at its sole expense and in its sole discretionexpense, to prepare, file, prosecute, enforce and maintain (including conducting or participating in interferences and oppositionsoppositions and the like) (collectively “Prosecute”) all Patents directed to Adimab Program Inventions but not falling within the Optioned Program Antibody Patents or the Adimab Platform Technology Improvements (which, to avoid doubt, are both addressed above).
Appears in 2 contracts
Samples: Development and Option Agreement (Surface Oncology, Inc.), Development and Option Agreement (Surface Oncology, Inc.)
Adimab Program Inventions. As between the Parties, Adimab shall have the sole right, at its sole expense and in its sole discretion, to prepare, file, prosecute, enforce and maintain (including conducting or participating in interferences and oppositions) all Patents directed to Adimab Program Inventions but not falling within the Optioned Program Antibody Patents or the Adimab Platform Platform/Core Technology Improvements (which, to avoid doubt, are both addressed above).
Appears in 2 contracts
Samples: Collaboration Agreement (Merrimack Pharmaceuticals Inc), Collaboration Agreement (Merrimack Pharmaceuticals Inc)
Adimab Program Inventions. As between the Parties, Adimab shall have the sole right, at its sole expense and in its sole discretion, to prepare, file, prosecute, enforce and maintain (including conducting or participating in interferences and oppositions) all Patents directed to Adimab Program Inventions but not falling within the Optioned Program Antibody Patents or the Adimab Platform Technology Improvements (which, to avoid doubt, are both addressed above).
Appears in 1 contract
Adimab Program Inventions. As between the Parties, Adimab shall have the sole right, at its sole expense and in its sole discretion, to prepare, file, prosecute, enforce and maintain (including conducting or participating in interferences and oppositions) all Program Patents directed to claiming Adimab Program Inventions but not falling within the Optioned Program Antibody Patents or Patents, the Adimab Platform Platform/Core Technology Improvements or Epitope Patents (which, to avoid doubt, are both all addressed above).
Appears in 1 contract